Article
JW Therapeutics launches $300M IPO in Hong Kong, targets first CAR T approval in China
Rating:
0.0
Views:
22
Likes:
1
Library:
1
CAR T therapy developer JW Therapeutics Co. Ltd. launched a HK$2.325 billion (US$300 million) IPO in Hong Kong by issuing 97.7 million shares at HK$23.8 apiece on Nov 3. The listing is set to help the company's march toward the goal of winning the first CAR T product approval in China.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value